Research News and Research

RSS

King Faisal Specialty Hospital implements LUMEDX CVIS in its Heart Centre

LUMEDX Corporation, a provider of vendor-neutral, integrated cardiovascular information and imaging systems (CVIS), announced today that the King Faisal Specialty Hospital and Research Centre has deployed a comprehensive LUMEDX CVIS in its Heart Centre.

15 Nov 2011

Scientists determine atomic structure of Lassa fever viral protein

Scientists at The Scripps Research Institute have determined the atomic structure of a protein that the Lassa fever virus uses to make copies of itself within infected cells.

15 Nov 2011

Moberg Derma receives Vinnova grant to develop Limtop for actinic keratosis, genital warts

Moberg Derma AB has been granted 4 MSEK by Vinnova for the development of Limtop, an innovative formulation for the treatment of actinic keratosis, genital warts and basal cell cancer.

15 Nov 2011

Covidien fourth quarter net sales increase 15% to $3.08 billion

Covidien plc today reported results for the fourth quarter of fiscal 2011.

15 Nov 2011

Midatech receives Swissmedic approval to start trial of insulin-coated gold nanoparticle

Midatech Ltd., a global leader in the design, development, synthesis and manufacture of nanomedicines, announced today it has received Swissmedic approval to start the First-in-Human clinical trial with insulin-coated gold nanoparticles, which will be coordinated through its Swiss subsidiary PharMida AG.

15 Nov 2011

InVivo Therapeutics reports net income of $3,067,000 for third quarter 2011

InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today reported financial results for the three and nine months ended September 30, 2011 and provided a business update.

15 Nov 2011

Scil Proteins completes manufacturing agreement with Lundbeck

Scil Proteins, a private biotech company specialized in the research, development and production of recombinant proteins, announced today the successful completion of a manufacturing agreement for Lundbeck, an international pharmaceutical company specializing in central nervous system disorders.

15 Nov 2011

Long-term AED therapy may increase risk of atherosclerosis in epilepsy patients

New research reveals that patients with epilepsy who were treated for extended periods with older generation antiepileptic drugs (AEDs) may be at increased risk for developing atherosclerosis, a common disorder known as hardening of the arteries.

15 Nov 2011

Tigecycline antibiotic shows promise against leukemia

Clinician-scientists in the Princess Margaret Cancer Program have found a promising approach to treating leukemia, using an old drug in a new way.

15 Nov 2011

Stem cell therapy within 2 or 3 weeks does not improve heart function after attack

A research network led by a Mayo Clinic physician found that stem cells obtained from bone marrow delivered two to three weeks after a person has a heart attack did not improve heart function.

15 Nov 2011

POZEN reports positive Phase 1 study results comparing PA32540 to clopidogrel for CVDs

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented positive results today from a Phase 1 study comparing a dose-timing strategy of PA32540 and clopidogrel spaced 10 hours apart as compared to synchronous administration of enteric-coated (EC) omeprazole (40 mg), enteric-coated aspirin (81 mg) and clopidogrel.

15 Nov 2011

Stem cell injections within two weeks may not help in post heart attack recovery

University Hospitals Case Medical Center researchers could still be close to giving heart attack patients a second chance-just not as they originally thought.

15 Nov 2011

Head hits appear to cause brain injury among high school players

The brain scans of high school football and hockey players showed subtle injury -- even if they did not suffer a concussion - after taking routine hits to the head during the normal course of play, according to a University of Rochester Medical Center study.

15 Nov 2011

Eliminating drug co-pays improves medication adherence in heart attack patients

The use of specific medications following a heart attack has been shown to reduce cardiovascular events and mortality, however; while highly effective, the rate of adherence to these medications is poor. Researchers from Brigham and Women's Hospital (BWH) evaluated whether eliminating co-payments for these medications would increase adherence and improve outcomes in patients who have had a heart attack.

15 Nov 2011

Clear link between erectile dysfunction and peripheral neuropathy

Spanish researchers have uncovered clear links between erectile dysfunction (ED) and peripheral neuropathy, according to a paper in the December issue of the urology journal BJUI.

15 Nov 2011

Supreme Court could announce today its plans for the health law

After a year and a half of legal skirmishing, President Obama's embattled health care law has arrived at the Supreme Court riding a surprising winning streak and carrying a constitutional stamp of approval from prominent conservative judges. … The Supreme Court is expected to announce as soon as Monday that it will hear the Florida case, the largest and broadest challenge to the Patient Protection and Affordable Care Act.

15 Nov 2011

Encouraging results from KAEL-GemVax GV1001 Phase II trial on NSCLC

KAEL-GemVax, a leading oncology biopharmaceutical company, today announced that results from a Phase II trial (CTN-2006) in Stage III non-small cell lung cancer (NSCLC) patients vaccinated with the telomerase peptide GV1001 after chemoradiotherapy and an 8-year update from a phase I/II trial have been published in the November issue of Clinical Cancer, the journal of the American Association for Cancer Research.

15 Nov 2011

Obama adminisration unveils plan to expand health care work force

The initiative, which is part of the White House's "We Can't Wait" agenda, will release funds to hire and train health workers as part of its effort to give the U.S. economy a boost.

15 Nov 2011

Survey of health opinion leaders finds 'unflagging' health overhaul support

In this survey, conducted by the Commonwealth Fund and Modern Healthcare, 89 percent of respondents supported moving forward with the measure's implementation. In related news, the National Committee for Quality Assurance plans this month to begin accrediting accountable care organizations. Meanwhile, in local coverage, North Carolina's health exchange grant remains unspent and a rural California county has its own health reform calculus.

15 Nov 2011

HIV and syphilis on the rise among MSM

Rates of HIV and syphilis are very high and rising among men who have sex with men (MSM) in New York City, reports a study in the November issue of JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

15 Nov 2011